pharma news today obesity drugs glp-1 today Lilly is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating ๐ The next trillion-dollar drug
Description
Two-Year Effects of Semaglutide in Adults with Overweight or Obesity: the STEP 5 Trial
Metoclopramide, domperidone and erythromycin have all been used in children with DGp [44]
Parvathaneni V, Kulkarni NS, Muth A, Gupta V
Mehrpour has authored over 250 peer-reviewed publications and is ranked among the top 2% of scientists worldwide
These antiinflammatory and antiatherogenic effects of GLP-1 RAs reduce formation of atherosclerotic lesions and progression (59, 60)
33,34 However, these studies are limited by the inability to identify NAION with electronic health record coding with absolute certainty
